1. Burden of chronic low back pain: Association with pain severity and prescription medication use in five large European countries. Issue 3 (26th November 2021) Authors: Perrot, Serge; Doane, Michael J.; Jaffe, Dena H.; Dragon, Erika; Abraham, Lucy; Viktrup, Lars; Bushmakin, Andrew G.; Cappelleri, Joseph C.; Conaghan, Philip G. Journal: Pain practice Issue: Volume 22:Issue 3(2022) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of Tadalafil on Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia and on Erectile Dysfunction in Sexually Active Men with Both Conditions: Analyses of Pooled Data from Four Randomized, Placebo‐Controlled Tadalafil Clinical Studies. (19th June 2013) Authors: Porst, Hartmut; Roehrborn, Claus G.; Secrest, Roberta J.; Esler, Anne; Viktrup, Lars Journal: Journal of sexual medicine Issue: Volume 10:Number 8(2013:Aug.) Page Start: 2044 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo‐controlled clinical studies. (22nd January 2017) Authors: Oelke, Matthias; Wagg, Adrian; Takita, Yasushi; Büttner, Hartwig; Viktrup, Lars Journal: BJU international Issue: Volume 119:Number 5(2017) Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of tadalafil 5 mg once‐daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double‐blind, parallel, placebo‐ and tamsulosin‐controlled study. (25th October 2018) Authors: Zhang, Zhichao; Li, Hanzhong; Zhang, Xiaodong; Dai, Yutian; Park, Hyun Jun; Jiann, Bang‐Ping; Li, Peng; Lou, Ying; Ye, Zhangqun; Viktrup, Lars Journal: International journal of urology Issue: Volume 26:Number 2(2019) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of tanezumab, NSAIDs, and placebo in patients with moderate to severe hip or knee osteoarthritis and a history of depression, anxiety, or insomnia: post-hoc analysis of phase 3 trials. (2nd November 2022) Authors: Mease, Philip; Kuritzky, Louis; Wright, Wendy L.; Mallick-Searle, Theresa; Fountaine, Robert; Yang, Ruoyong; Sadrarhami, Mojgan; Faison, Warachal; Johnston, Elizabeth; Viktrup, Lars Journal: Current medical research and opinion Issue: Volume 38:Number 11(2022) Page Start: 1909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Erectile dysfunction with or without coexisting benign prostatic hyperplasia in the general US population: analysis of US National Health and Wellness Survey. (December 2013) Authors: Foster, Shonda A.; Annunziata, Kathy; Shortridge, Emily F.; Freedman, Deborah; Viktrup, Lars Journal: Current medical research and opinion Issue: Volume 29:Number 12(2013:Dec.) Page Start: 1709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Exploring patient preference heterogeneity for pharmacological treatments for chronic pain: A latent class analysis. (8th January 2022) Authors: Walsh, David A.; Boeri, Marco; Abraham, Lucy; Atkinson, Jo; Bushmakin, Andrew G.; Cappelleri, Joseph C.; Hauber, Brett; Klein, Kathleen; Russo, Leo; Viktrup, Lars; Turk, Dennis Journal: European journal of pain Issue: Volume 26:Number 3(2022) Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgroup analysis of placebo‐controlled trials. Issue 12 (21st October 2021) Authors: Berenbaum, Francis; Schnitzer, Thomas; Kivitz, Alan; Viktrup, Lars; Johnston, Elizabeth; Yang, Ruoyong; Whalen, Ed; Tive, Leslie; Semel, David Journal: International journal of clinical practice Issue: Volume 75:Issue 12(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo‐Controlled Trials. Issue 6 (25th March 2022) Authors: Berenbaum, Francis; Schnitzer, Thomas J.; Kivitz, Alan J.; Viktrup, Lars; Hickman, Anne; Pixton, Glenn; Brown, Mark T.; Davignon, Isabelle; West, Christine R. Journal: Arthritis care & research Issue: Volume 74:Issue 6(2022) Page Start: 918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. LB0007 SUBCUTANEOUS TANEZUMAB FOR OSTEOARTHRITIS PAIN: A 24-WEEK PHASE 3 STUDY WITH A 24-WEEK FOLLOW UP. (June 2019) Authors: Berenbaum, Francis; Blanco, Francisco J.; Guermazi, Ali; Vignon, Eric; Miki, Kenji; Yamabe, Takaharu; Viktrup, Lars; Junor, Rod; Carey, William; Brown, Mark; Verburg, Ken; West, Christine Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗